These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34576231)

  • 1. Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review.
    Romano MR; Catania F; Confalonieri F; Zollet P; Allegrini D; Sergenti J; Lanza FB; Ferrara M; Angi M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
    Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pre-enucleation radiotherapy on mitotic activity of choroidal and ciliary body melanomas.
    Augsburger JJ; Eagle RC; Chiu M; Shields JA
    Ophthalmology; 1987 Dec; 94(12):1627-30. PubMed ID: 3431833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Episcleral plaque radiotherapy for uveal melanoma.
    Giblin ME; Shields JA; Augsburger JJ; Brady LW
    Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular collision tumour: case report and literature review.
    Coupland SE; Dodson A; Liu H; Du MQ; Angi M; Damato BE
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1383-8. PubMed ID: 23232651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach.
    Angi M; Kalirai H; Taktak A; Hussain R; Groenewald C; Damato BE; Heimann H; Coupland SE
    Br J Ophthalmol; 2017 Aug; 101(8):1143-1146. PubMed ID: 28596284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
    Konstantinidis L; Groenewald C; Coupland SE; Damato B
    Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoresection following proton beam irradiation of large uveal melanomas].
    Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
    Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trans-scleral resection of the ciliary body and choroidal melanoma].
    Romanowska-Dixon B; Starzycka M; Pogrzebielski A
    Klin Oczna; 2000; 102(5):323-6. PubMed ID: 11286105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and therapy of malignant melanoma of the uvea (choroid and ciliary body)].
    Bornfeld N
    Ophthalmologe; 1992 Dec; 89(6):W61-78. PubMed ID: 1486257
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
    Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
    Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body.
    Liszauer AD; Brownstein S; Corriveau C; Deschênes J
    Can J Ophthalmol; 1990 Dec; 25(7):340-4. PubMed ID: 2090338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension.
    Pach JM; Robertson DM; Taney BS; Martin JA; Campbell RJ; O'Brien PC
    Am J Ophthalmol; 1986 Mar; 101(3):325-31. PubMed ID: 3953727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical Methods in the Treatment of Uveal Melanoma].
    Blatsios G; Haas G; Zehetner C; Bechrakis NE
    Klin Monbl Augenheilkd; 2017 Jul; 234(7):874-885. PubMed ID: 28743137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
    Chia SN; Smith HB; Hammer HM; Kemp EG
    Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.